Press & News
The next generation biopharmaceuticals
Press releases 2012
2012-04-27
Older press releases
2012-02-10
2012-02-02
Affibody AB and Creative Antibiotics AB enter collaboration to develop targeted antibiotics.
Affibody in short
Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
Upcoming reports Financial calendar
- Interim Report Q2 (August 23, 2018)